Feng-Ying C. Lin
National Institute of Child Health and Human Development
National Institutes of Health
Bethesda
MD 20892-7510
USA
Name/email consistency: medium
- Phylogenetic lineages of invasive and colonizing strains of serotype III group B Streptococci from neonates: a multicenter prospective study. Lin, F.Y., Whiting, A., Adderson, E., Takahashi, S., Dunn, D.M., Weiss, R., Azimi, P.H., Philips, J.B., Weisman, L.E., Regan, J., Clark, P., Rhoads, G.G., Frasch, C.E., Troendle, J., Moyer, P., Bohnsack, J.F. J. Clin. Microbiol. (2006)
- Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen. Lin, F.Y., Weisman, L.E., Azimi, P.H., Philips, J.B., Clark, P., Regan, J., Rhoads, G.G., Frasch, C.E., Gray, B.M., Troendle, J., Brenner, R.A., Moyer, P., Clemens, J.D. J. Infect. Dis. (2004)
- Prematurity is the major risk factor for late-onset group B streptococcus disease. Lin, F.Y., Weisman, L.E., Troendle, J., Adams, K. J. Infect. Dis. (2003)
- The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. Lin, F.Y., Ho, V.A., Khiem, H.B., Trach, D.D., Bay, P.V., Thanh, T.C., Kossaczka, Z., Bryla, D.A., Shiloach, J., Robbins, J.B., Schneerson, R., Szu, S.C. N. Engl. J. Med. (2001)
- Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study. Lin, F.Y., Philips, J.B., Azimi, P.H., Weisman, L.E., Clark, P., Rhoads, G.G., Regan, J., Concepcion, N.F., Frasch, C.E., Troendle, J., Brenner, R.A., Gray, B.M., Bhushan, R., Fitzgerald, G., Moyer, P., Clemens, J.D. J. Infect. Dis. (2001)
- Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998. Lin, F.Y., Azimi, P.H., Weisman, L.E., Philips, J.B., Regan, J., Clark, P., Rhoads, G.G., Clemens, J., Troendle, J., Pratt, E., Brenner, R.A., Gill, V. Clin. Infect. Dis. (2000)
